Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2014

Shareholders' Equity

Share-Based Activity

	Three Months Ended March 31,
	2014		2013
Share-based compensation expense	$	2,458	$	2,050
Fair value of shares vested		9,175		9,182
Cash received from option exercises		488		5,691
Tax benefit from option exercises		1,727		288

Schedule Of Changes In Non-Vested Restricted Shares

			Weighted
		Number	Average
		of Shares	Grant Price
Non-vested shares at December 31, 2013		743,869	$	26.54
	Shares granted	200,391		42.38
	Shares vested	(218,405)		21.62
Non-vested shares at March 31, 2014		725,855	$	32.40

Schedule Of Stock Option Activity

					Weighted
					Average
			Weighted		Remaining
		Number	Average		Contractual
		of Shares	Exercise Price		Term (in years)
Outstanding at December 31, 2013		270,464	$	23.16	2.5
	Options exercised with total intrinsic value of $488,000	(19,921)		24.49
Outstanding at March 31, 2014 with aggregate intrinsic value of $6,020,000		250,543	$	23.05	2.2
Vested at March 31, 2014 with aggregate intrinsic value of $6,020,000		250,543	$	23.05	2.2
Exercisable at March 31, 2014 with aggregate intrinsic value of $6,020,000		250,543	$	23.05	2.2

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

		Three Months Ended March 31,
		Earnings		Shares	Per Share
		(Numerator)		(Denominator)	Amount
2014:
Net earnings from continuing operations attributable to AmSurg Corp. per common share (basic)		$	17,504	31,716	$	0.55
Effect of dilutive securities options and non-vested shares			-	404
	Net earnings from continuing operations attributable to AmSurg Corp. per common share (diluted)	$	17,504	32,120	$	0.55
Net earnings attributable to AmSurg Corp. per common share (basic)		$	17,195	31,716	$	0.54
Effect of dilutive securities options and non-vested shares			-	404
	Net earnings attributable to AmSurg Corp. per common share (diluted)	$	17,195	32,120	$	0.54
2013:
Net earnings from continuing operations attributable to AmSurg Corp. per common share (basic)		$	17,750	31,217	$	0.57
Effect of dilutive securities options and non-vested shares			-	664
	Net earnings from continuing operations attributable to AmSurg Corp. per common share (diluted)	$	17,750	31,881	$	0.56
Net earnings attributable to AmSurg Corp. per common share (basic)		$	17,811	31,217	$	0.57
Effect of dilutive securities options and non-vested shares			-	664
	Net earnings attributable to AmSurg Corp. per common share (diluted)	$	17,811	31,881	$	0.56